These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
5. The role of hepassocin in the development of non-alcoholic fatty liver disease. Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031 [TBL] [Abstract][Full Text] [Related]
6. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells. Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174 [TBL] [Abstract][Full Text] [Related]
7. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Katoh M; Katoh M Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704 [TBL] [Abstract][Full Text] [Related]
8. Saturated Fatty Acid-Induced Impairment of Hepatic Lipid Metabolism Is Worsened by Prohibitin 1 Deficiency in Hepatocytes. Yanran W; Jung S; Ko KS J Med Food; 2022 Aug; 25(8):845-852. PubMed ID: 35980329 [TBL] [Abstract][Full Text] [Related]
9. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X; Chen S; Zhang L Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319 [TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. Wang Y; Li JY; Han M; Wang WL; Li YZ Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes. Chen H; Zhang L; Li X; Li X; Sun G; Yuan X; Lei L; Liu J; Yin L; Deng Q; Wang J; Liu Z; Yang W; Wang Z; Zhang H; Liu G J Steroid Biochem Mol Biol; 2013 Nov; 138():445-54. PubMed ID: 23994141 [TBL] [Abstract][Full Text] [Related]
13. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
14. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437 [TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325 [TBL] [Abstract][Full Text] [Related]
19. Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver. Du X; Shen T; Wang H; Qin X; Xing D; Ye Q; Shi Z; Fang Z; Zhu Y; Yang Y; Peng Z; Zhao C; Lv B; Li X; Liu G; Li X J Dairy Sci; 2018 Oct; 101(10):9544-9558. PubMed ID: 30100495 [TBL] [Abstract][Full Text] [Related]
20. Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease. Li T; Yan H; Geng Y; Shi H; Li H; Wang S; Wang Y; Xu J; Zhao G; Lu X Lipids Health Dis; 2019 Dec; 18(1):211. PubMed ID: 31805951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]